Holdings (Monthly)
Guide ↗
JPMorgan Healthcare Leaders ETF
· J.P. Morgan Exchange-Traded Fund Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 478160104 | Apr 2024 | 2,868 | $652K | 7.43% | EC |
| 2 | Eli Lilly & Co. | 532457108 | Apr 2024 | 609 | $632K | 7.20% | EC |
| 3 | AbbVie, Inc. | 00287Y109 | Apr 2024 | 2,129 | $475K | 5.41% | EC |
| 4 | Merck & Co., Inc. | 58933Y105 | Apr 2024 | 4,066 | $448K | 5.11% | EC |
| 5 | AstraZeneca plc | N/A | Apr 2024 | 2,242 | $418K | 4.76% | EC |
| 6 | Novo Nordisk A/S | N/A | Apr 2024 | 5,388 | $320K | 3.65% | EC |
| 7 | UnitedHealth Group, Inc. | 91324P102 | Apr 2024 | 1,067 | $306K | 3.49% | EC |
| 8 | Danaher Corp. | 235851102 | Apr 2024 | 1,268 | $278K | 3.16% | EC |
| 9 | Medtronic plc | N/A | Apr 2024 | 2,643 | $272K | 3.10% | EC |
| 10 | Roche Holding AG | N/A | Apr 2024 | 564 | $256K | 2.92% | EC |
| 11 | Bristol-Myers Squibb Co. | 110122108 | Apr 2024 | 3,881 | $214K | 2.43% | EC |
| 12 | Boston Scientific Corp. | 101137107 | Apr 2024 | 2,272 | $213K | 2.42% | EC |
| 13 | CVS Health Corp. | 126650100 | Jan 2026 | 2,827 | $211K | 2.40% | EC |
| 14 | McKesson Corp. | 58155Q103 | Apr 2024 | 221 | $184K | 2.09% | EC |
| 15 | Argenx SE | N/A | Apr 2024 | 218 | $183K | 2.09% | EC |
| 16 | Regeneron Pharmaceuticals, Inc. | 75886F107 | Apr 2024 | 247 | $183K | 2.09% | EC |
| 17 | Lonza Group AG | N/A | Apr 2024 | 252 | $171K | 1.95% | EC |
| 18 | EssilorLuxottica SA | N/A | Apr 2024 | 551 | $168K | 1.92% | EC |
| 19 | Hoya Corp. | N/A | Apr 2024 | 1,000 | $168K | 1.91% | EC |
| 20 | UCB SA | N/A | Apr 2024 | 544 | $166K | 1.89% | EC |
| 21 | Vertex Pharmaceuticals, Inc. | 92532F100 | Jan 2026 | 344 | $162K | 1.84% | EC |
| 22 | Stryker Corp. | 863667101 | Apr 2024 | 406 | $150K | 1.71% | EC |
| 23 | Thermo Fisher Scientific, Inc. | 883556102 | Apr 2024 | 254 | $147K | 1.67% | EC |
| 24 | Cardinal Health, Inc. | 14149Y108 | Jan 2026 | 679 | $146K | 1.66% | EC |
| 25 | Edwards Lifesciences Corp. | 28176E108 | Apr 2024 | 1,781 | $145K | 1.65% | EC |
| 26 | IQVIA Holdings, Inc. | 46266C105 | Apr 2024 | 544 | $125K | 1.43% | EC |
| 27 | Intuitive Surgical, Inc. | 46120E602 | Apr 2024 | 235 | $118K | 1.35% | EC |
| 28 | Teva Pharmaceutical Industries Ltd. | N/A | Apr 2024 | 3,182 | $108K | 1.23% | EC |
| 29 | Fresenius SE & Co. KGaA | N/A | Apr 2024 | 1,875 | $105K | 1.19% | EC |
| 30 | Novartis AG | N/A | Apr 2024 | 672 | $100K | 1.14% | EC |
| 31 | Sartorius AG | N/A | Apr 2024 | 327 | $91K | 1.04% | EC |
| 32 | Biogen, Inc. | 09062X103 | Apr 2024 | 460 | $83K | 0.94% | EC |
| 33 | Axsome Therapeutics, Inc. | 05464T104 | Jan 2026 | 429 | $79K | 0.90% | EC |
| 34 | Ionis Pharmaceuticals, Inc. | 462222100 | Jan 2026 | 943 | $78K | 0.89% | EC |
| 35 | Apogee Therapeutics, Inc. | 03770N101 | Jan 2026 | 1,116 | $73K | 0.83% | EC |
| 36 | Neurocrine Biosciences, Inc. | 64125C109 | Apr 2024 | 498 | $68K | 0.77% | EC |
| 37 | Ascendis Pharma A/S | 04351P101 | Jan 2026 | 297 | $67K | 0.77% | EC |
| 38 | Genmab A/S | N/A | Apr 2024 | 199 | $65K | 0.74% | EC |
| 39 | United Therapeutics Corp. | 91307C102 | Jan 2026 | 136 | $64K | 0.73% | EC |
| 40 | Immunome, Inc. | 45257U108 | Jan 2026 | 2,513 | $62K | 0.70% | EC |
| 41 | Disc Medicine, Inc. | 254604101 | Jan 2026 | 759 | $59K | 0.67% | EC |
| 42 | Daiichi Sankyo Co. Ltd. | N/A | Apr 2024 | 3,200 | $59K | 0.67% | EC |
| 43 | Viridian Therapeutics, Inc. | 92790C104 | Jan 2026 | 1,743 | $58K | 0.66% | EC |
| 44 | Dyne Therapeutics, Inc. | 26818M108 | Jan 2026 | 3,200 | $57K | 0.65% | EC |
| 45 | CG oncology, Inc. | 156944100 | Jan 2026 | 1,052 | $55K | 0.62% | EC |
| 46 | Convatec Group plc | N/A | Apr 2024 | 16,261 | $51K | 0.58% | EC |
| 47 | Revolution Medicines, Inc. | 76155X100 | Apr 2024 | 455 | $44K | 0.50% | EC |
| 48 | Waters Corp. | 941848103 | Jan 2026 | 116 | $43K | 0.49% | EC |
| 49 | Cytokinetics, Inc. | 23282W605 | Jan 2026 | 679 | $43K | 0.49% | EC |
| 50 | Bio-Techne Corp. | 09073M104 | Jan 2026 | 633 | $41K | 0.46% | EC |
| 51 | Cigna Group (The) | 125523100 | Apr 2024 | 142 | $39K | 0.44% | EC |
| 52 | Xenon Pharmaceuticals, Inc. | 98420N105 | Jan 2026 | 913 | $37K | 0.43% | EC |
| 53 | Align Technology, Inc. | 016255101 | Apr 2024 | 228 | $37K | 0.42% | EC |
| 54 | Terns Pharmaceuticals, Inc. | 880881107 | Jan 2026 | 903 | $31K | 0.36% | EC |
| 55 | HCA Healthcare, Inc. | 40412C101 | Apr 2024 | 60 | $29K | 0.33% | EC |
| 56 | Alnylam Pharmaceuticals, Inc. | 02043Q107 | Apr 2024 | 84 | $28K | 0.32% | EC |
| 57 | Argenx SE | N/A | Apr 2024 | 27 | $23K | 0.26% | EC |
| 58 | Genmab A/S | 372303206 | Jan 2026 | 393 | $13K | 0.15% | EC |
| 59 | Legend Biotech Corp. | 52490G102 | Jan 2026 | 167 | $3K | 0.03% | EC |
| 60 | EURO | N/A | Apr 2024 | 717 | $850 | 0.01% | STIV |
| 61 | Israeli Shekel | N/A | Apr 2024 | 1,840 | $594 | 0.01% | STIV |
| 62 | Swiss Franc | N/A | Apr 2024 | 0 | $0 | 0.00% | STIV |
| 63 | Danish Krone | N/A | Apr 2024 | -0 | $0 | 0.00% | STIV |
| 64 | Japanese Yen | N/A | Apr 2024 | -1 | $-0 | 0.00% | STIV |
| 65 | British Pound | N/A | Apr 2024 | -0 | $-0 | -0.00% | STIV |